Your Messages Inbox
Your Article Summary
See Latest ArticlesBioMimetic Therapeutics, Inc. Announces Extension of Rights Offering
BioMimetic Therapeutics, 06/16/09
BioMimetic Therapeutics, Inc. announced that the Company has approved a seven-day extension of the Company's pending subscription rights offering on June 2009, unless further extended by the Company. Pursuant to the subscription rights offering, each holder of record of the Company's common stock as of April 2009 received one non-transferable subscription right for each share of common stock owned by such holder on such date, except with respect to shares of common stock held by the BioMimetic 401K Plan.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Astellas Inducted into National Minority Transplant Hall of Fame
Astellas, 12/09/09
Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Amgen, 12/08/09
Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
b3c newswire, 12/07/09
Article Search
Sponsor